A Nobel for biochemistry underlying COVID-19 vaccines
Hungarian-born and American today won the 2023 Nobel Prize in physiology or medicine “for their discoveries concerning nucleoside base modifications that enabled the development of effective (messenger) RNA vaccines against COVID-19.”
Karik贸 and Weissman performed the groundbreaking research at the University of Pennsylvania and published their earliest findings in the late 1990s and early 2000s.
Their work was all about demonstrating that an mRNA vaccine must find the “Goldilocks” zone while interacting with the immune system. Too much recognition by the immune system by an mRNA vaccine could lead to immediate elimination of the vaccine material and intense patient symptoms. On the other end of the spectrum, too little mRNA interaction with the immune system could make the vaccine to go undetected, failing to induce the required immunity to protect a patient from future disease.
Karik贸 and Weissman found the answer in pseudouridine, a naturally occurring, posttranscriptional RNA modification of the building block uridine that alters RNA–RNA and RNA–protein interactions and affects gene expression.
Kariko was senior vice president and head of RNA protein replacement at until 2022 and has since acted as an adviser to the company. She is also a professor at the University of Szeged in Hungary and an adjunct professor at the UPenn School of Medicine. Weissman is a professor of vaccine research at the UPenn School of Medicine. The two met at the university in the late 1990s while using a photocopier, according to a .
In 2004 in the , Karik贸 and Weissman detailed that mRNA secondary structure activates the immune system to produce proinflammatory cytokines via binding to Toll-like receptor 3, a nucleotide-sensing TLR that is activated by double-stranded RNA, a sign of viral infection or necrotic tissue.
One year later, Karik贸 and Weissman demonstrated how nucleoside modifications can suppress the immunological response to RNA stemming from bacteria or necrotic tissue. They published their findings in the journal Immunity in a paper titled
Karik贸 and Weissman further refined the production of laboratory transcribed mRNA for COVID-19 vaccination by optimizing the use of pseudouridine to suppress the capacity of vaccine mRNA to activate immune cells called dendritic cells. They found that incorporating pseudouridine, as a replacement of uridine, into the lab transcribed mRNA could suppress unwanted immunological side effects of vaccination.
Thomas Perlmann, the secretary of the Nobel Committee for Physiology or Medicine 2023, phoned each laureate before making the public announcement in Swedish and English. "They were very happy,” Perlmann said. He inquired whether the scientists were surprised by the announcement because he suspected “they may not be, having received many prizes.” However, both Karik贸 and Weissman were surprised and overwhelmed by the news, Perlmann said.
, president of the 91亚色传媒 and professor of biochemistry and molecular biology at Rutgers University, said she hopes the prize will motivate current and future students to study biochemistry.
“The awarding of the Nobel prize to two biochemists for the application of pseudouridine to development of mRNA therapies highlights the relevance of fundamental biochemistry and should be motivational for students, especially medical students, who sometimes lack enthusiasm for learning about the nucleoside and amino acid building blocks of nucleic acids and proteins,” Stock said.
This achievement was particularly overwhelming for Karik贸, Perlmann said, because she never received a tenured position at UPenn or an R01 grant from the National Institutes of Health, which Perlmann described as a “clear sign that she struggled and didn't get recognition for the importance of her vision.”
JBC Editor-in-Chief offered his congratulations to the Nobel laurates.
“Their discovery … was instrumental in the design of mRNA vaccines and ultimately paved the way for the development of the COVID-19 vaccine therapies that saved millions of lives during the recent pandemic,” Toker said. “This underscores the importance of fundamental discoveries in basic mechanisms of cell and molecular biology and their transformative impact on human health. I applaud the Nobel committee for recognizing these two extraordinary scientists and their discoveries.”
, chair of the Nobel committee, emphasized how much this “flexible and fast” platform has and will continue to impact the general population and cited current research developments on influenza and therapeutic cancer mRNA vaccines.
, a professor of chemistry at the University of Massachusetts Chan Medical School who studies the structure and function in enzyme–nucleic acid interactions, added: “Karik贸 and Weissman have launched a field that is just now emerging. mRNA vaccines are just the beginning. mRNA can deliver therapeutic proteins to cells and offers the promise of personalized cancer therapies. It is truly an exciting time for mRNA!"
Vaccine skepticism has plagued the public and made many pause before getting immunized against SARS-CoV-2. In fact, early in the COVID-19 pandemic, 31.6% of the U.S. population was about receiving a vaccine, and 10.8% stated that they would refuse.
During a Q&A session after the announcement, a reporter asked the Nobel committee representatives if they considered the prize a “powerful strike back for the anti-vaccine movement.”
Olle K盲mpe of the Karolinska Institutet, vice chair of the committee, noted that more than 13 billion people have gotten the vaccine and that, while the award would probably not sway those most resistant, "giving a Nobel Prize for this COVID-19 vaccine may make hesitant people take the vaccine and be sure it's very efficient and safe."
, who received the 2013 Nobel Prize in physiology or medicine for his work on the “discoveries of machinery regulating vesicle traffic,” said: “This morning’s announcement is a welcome antidote to the toxic nonsense spread by vaccine skeptics who use misinformation to sow confusion and doubt.”
Enjoy reading 91亚色传媒 Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from 91亚色传媒 Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
Sung honored for research; Sliger, Young named astronaut scholars
Patrick Sung receives the 2024 Basser Global Prize from the Basser Center for BRCA at Penn Medicine. A foundation created by Mercury 7 astronauts awards scholarships to Shelby Sliger and Tara Young.
鈥極ur work is about science transforming people鈥檚 lives鈥
Ann West, chair of the 91亚色传媒 Public Affairs Advisory Committee, sits down Monica Bertagnolli, director of the National Institutes of Health.
Pernas named fellow; Heitman and Wu elected to NAM
Lena Pernas is named a fellow by the David and Lucile Packard Foundation. Joseph Heitman and Hao Wu are inducted into the National Academy of Medicine.
Awards for Maquat and Gohil; Sobrado named biochem chair
Vishal Gohil is honored for work with copper. Lynn Maquat receives two awards for RNA research. Pablo Sobrado is named endowed chair of biochemistry.
What seems dead may not be dead
Vincent Tagliabracci will receive the Earl and Thressa Stadtman Distinguished Scientist Award at the 91亚色传媒 Annual Meeting, April 12鈥15 in Chicago.
'You can't afford to be 15 years behind the parasite'
David Fidock will receive the Alice and C.C. Wang Award in Molecular Parasitology at the 2025 91亚色传媒 Annual Meeting, April 12鈥15 in Chicago.